Patent protection barriers not holding back vaccine production: drug groups say
Reuters | Mar 09, 2021 08:47 PM EST A woman holds a small bottle labelled with a Coronavirus COVID-19 Vaccine sticker in this illustration taken, (Photo : REUTERS/Dado Ruvic/File Photo)
Manufacturing capacity and ingredients shortages are the main bottlenecks to expanding COVID-19 vaccine production, several global drug groups said on Tuesday, not patents that some critics are demanding be removed. IP (intellectual property) rights is not the issue, said Thomas Cueni, who heads the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA).
Advertisement
Like Us on Facebook The bottlenecks are the capacity, the scarcity of raw materials, scarcity of ingredients, and it is about the know-how.
Chatham House says that the signs of input supply challenges are being observed across all vaccine manufacturing steps which include bioreactor bags, single-use systems, cell culture media (upstream), filters, gamma sterilisation (upstream and downstream)
March 10, 2021 | 12:26 pm Font Size
AAA
ZURICH â Manufacturing capacity and ingredients shortages are the main bottlenecks to expanding coronavirus disease 2019 (COVID-19) vaccine production, several global drug groups said on Tuesday, not patents that some critics are demanding be removed.
âIP (intellectual property) rights is not the issue,â said Thomas Cueni, who heads the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA).
âThe bottlenecks are the capacity, the scarcity of raw materials, scarcity of ingredients, and it is about the know-how.â
Mr. Cueni, who represents large drugmakers, spoke after a virtual meeting organized partly by the World Health Organization-backed COVAX vaccine sharing program. It included manufacturers, suppliers, and international organizations seeking to boost vaccine supplies.
No contract signed to produce Russian COVID-19 shot, France says No company in France has signed a contract with Russia to produce its Sputnik V COVID-19 vaccine, a spokesman for France's industry minister said on Tuesday, appearing to contradict the head of Russia's RDIF sovereign wealth fund.
Australia hesitant to back plan to let poor countries make cheap copies of Covid vaccines msn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from msn.com Daily Mail and Mail on Sunday newspapers.